Cargando…

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

Detalles Bibliográficos
Autores principales: Ratner, L, Rauch, D, Abel, H, Caruso, B, Noy, A, Barta, S K, Parekh, S, Ramos, J C, Ambinder, R, Phillips, A, Harding, J, Baydoun, H H, Cheng, X, Jacobson, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817103/
https://www.ncbi.nlm.nih.gov/pubmed/27015285
http://dx.doi.org/10.1038/bcj.2016.21
_version_ 1782424840702001152
author Ratner, L
Rauch, D
Abel, H
Caruso, B
Noy, A
Barta, S K
Parekh, S
Ramos, J C
Ambinder, R
Phillips, A
Harding, J
Baydoun, H H
Cheng, X
Jacobson, S
author_facet Ratner, L
Rauch, D
Abel, H
Caruso, B
Noy, A
Barta, S K
Parekh, S
Ramos, J C
Ambinder, R
Phillips, A
Harding, J
Baydoun, H H
Cheng, X
Jacobson, S
author_sort Ratner, L
collection PubMed
description
format Online
Article
Text
id pubmed-4817103
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48171032016-04-14 Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma Ratner, L Rauch, D Abel, H Caruso, B Noy, A Barta, S K Parekh, S Ramos, J C Ambinder, R Phillips, A Harding, J Baydoun, H H Cheng, X Jacobson, S Blood Cancer J Letter to the Editor Nature Publishing Group 2016-03 2016-03-25 /pmc/articles/PMC4817103/ /pubmed/27015285 http://dx.doi.org/10.1038/bcj.2016.21 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Ratner, L
Rauch, D
Abel, H
Caruso, B
Noy, A
Barta, S K
Parekh, S
Ramos, J C
Ambinder, R
Phillips, A
Harding, J
Baydoun, H H
Cheng, X
Jacobson, S
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
title Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
title_full Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
title_fullStr Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
title_full_unstemmed Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
title_short Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
title_sort dose-adjusted epoch chemotherapy with bortezomib and raltegravir for human t-cell leukemia virus-associated adult t-cell leukemia lymphoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817103/
https://www.ncbi.nlm.nih.gov/pubmed/27015285
http://dx.doi.org/10.1038/bcj.2016.21
work_keys_str_mv AT ratnerl doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT rauchd doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT abelh doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT carusob doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT noya doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT bartask doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT parekhs doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT ramosjc doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT ambinderr doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT phillipsa doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT hardingj doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT baydounhh doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT chengx doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma
AT jacobsons doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma